Get an alert when INSTEM LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-02-19 (in 9mo)

Last made up 2026-02-05

Watchouts

1 item

Cash

£13M

+14.9% vs 2023

Net assets

£54M

+15.7% vs 2023

Employees

468

-12.2% vs 2023

Profit before tax

-£4M

+60.5% vs 2023

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £59,819,000£55,269,000
Operating profit £297,000£2,282,000
Profit before tax -£9,405,000-£3,716,000
Net profit -£7,918,000-£4,643,000
Cash £11,720,000£13,465,000
Total assets less current liabilities
Net assets £46,415,000£53,695,000
Equity £46,415,000£53,695,000
Average employees 533468
Wages £28,503,000£25,638,000
Directors' remuneration £477,000£452,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 0.5%4.1%
Net margin -13.2%-8.4%
Gearing (liabilities / total assets) 47.7%42.1%
Current ratio 0.75x0.87x
Interest cover 0.22x3.05x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 4 times since incorporation

  1. INSTEM LIMITED 2023-12-12 → present
  2. INSTEM PLC 2012-01-13 → 2023-12-12
  3. INSTEM LIFE SCIENCE SYSTEMS PLC 2010-10-07 → 2012-01-13
  4. INSTEM LIFE SCIENCE SYSTEMS LIMITED 2010-09-24 → 2010-10-07
  5. HELIUM MIRACLE 99 LIMITED 2010-02-05 → 2010-09-24

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Consolidated group
Auditor
PKF Littlejohn LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“After considering the uncertainties described above, the directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future and as a minimum until 30 June 2026 For these reasons, they continue to adopt the going concern basis in preparing this annual report and accounts.”

Group structure

  1. INSTEM LIMITED · parent
    1. Instem Life Science Systems Limited 100% · England and Wales · Holding company
    2. Instem LSS Limited 100% · England and Wales · Software development, sales, sales support and administrative support
    3. Instem LSS (North America) Limited 100% · England and Wales · Sales, sales support and administrative support
    4. Instem LSS (Asia) Limited 100% · Hong Kong · Holding company
    5. Instem Information Systems (Shanghai) Limited 100% · Shanghai, PRC · Sales, sales support and service
    6. Instem Scientific Limited 100% · England and Wales · Leading provider of software solutions for extracting intelligence from R&D related healthcare data
    7. Instem Scientific Solutions Limited 100% · England and Wales · Dormant
    8. Instem Scientific Inc. 100% · USA · Leading provider of software solutions for extracting intelligence from R&D related healthcare data
    9. Instem India Pvt Limited 99.9% · India · Software development
    10. Instem Clinical Holdings Limited 100% · England and Wales · Holding Company
    11. Instem Clinical Limited 100% · England and Wales · Provision of electronic data capture and clinical management solutions to the pharmaceutical industry
    12. Instem Clinical Inc. 100% · USA · Provision of electronic data capture and clinical management solutions to the pharmaceutical industry
    13. Trimetra Limited 100% · England and Wales · Software development and consultancy
    14. Perceptive Instruments Limited 100% · England and Wales · Development, manufacture and supply of software and hardware products for in vitro study data collection and study management in the genetic toxicology, microbiology and immunology markets
    15. Instem Japan K.K 100% · Japan · Sales, sales support and service
    16. Notocord Systems S.A. 100% · France · Software development, sales support and administrative support
    17. Notocord Inc. 100% · USA · Sales, sales support and administrative support
    18. Leadscope Inc. 100% · USA · Leading provider of in-silico safety assessment software
    19. The Edge Software Consultancy Limited 100% · England and Wales · Software development, sales, sales support and consultancy activities
    20. d-Wise Technologies UK Limited 100% · England and Wales · Software development, sales, sales support and consultancy activities on clinical trial analysis
    21. Instem Inc 100% · USA · Holding Company
    22. d-Wise Technologies Inc 100% · USA · Software development, sales, sales support and consultancy activities on clinical trial analysis
    23. d-Wise Technologies Inc., Morrisville succursale de Genève Branch 100% · Switzerland · Software development, sales, sales support and consultancy activities on clinical trial analysis
    24. d-Wise Technologies Deutschland GmbH 100% · Germany · Software development, sales, sales support and consultancy activities on clinical trial analysis
    25. Pathology Data Systems AG 100% · Switzerland · Software development, sales, sales support and provider of regulatory information management software
    26. Preclinical Data Systems, Inc. 100% · USA · Software development
    27. Pathology Data Systems Ltd Japan Branch 100% · Japan · Software development
    28. Pathology Data Systems AG PRATTELN - SUCURSALA CRAIOVA 100% · Romania · Software development

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 20 resigned

Name Role Appointed Born Nationality
OAKWOOD CORPORATE SECRETARY LIMITED Corporate Secretary 2025-10-13
GUILLAUMOT, Vincent Director 2024-02-05 Feb 1978 French
KRISHNAN, Vikram Venkatesh Director 2025-10-13 Apr 1981 American
Show 20 resigned officers
Name Role Appointed Resigned
GOLDSMITH, Nigel John Secretary 2011-11-29 2023-11-25
MCLAUCHLAN, James Secretary 2010-09-15 2011-08-08
SHERWIN, David Michael Secretary 2011-08-08 2011-11-29
OAKWOOD CORPORATE SECRETARY LIMITED Corporate Secretary 2010-02-05 2010-09-15
BANDALI, Riaz Amirali Director 2021-12-01 2023-11-20
BERGER, Marc Director 2023-11-20 2024-02-05
DOLSON, Mary Ruth Director 2023-01-09 2023-11-20
FARIAS-EISNER, Anthony Giorgio Director 2024-02-05 2026-04-20
FLINOIS, Xavier Director 2023-11-20 2024-02-05
GARE, David Director 2010-09-15 2023-11-20
GOLDSMITH, Nigel John Director 2024-02-05 2024-04-19
GOLDSMITH, Nigel John Director 2011-11-29 2023-11-20
HARRIS, Michael Paul Director 2010-02-05 2010-09-15
MCGOUN, Michael Frederick Director 2010-09-15 2023-11-20
MCLAUCHLAN, James Director 2010-09-15 2011-08-08
REASON, Philip John Director 2010-09-15 2025-10-13
SENDEROVITZ, Thomas Director 2023-11-27 2024-02-05
SHERWIN, David Michael Director 2010-09-15 2023-01-31
THIRUKAILAYANATHAN, Jegan Director 2024-04-19 2026-02-24
THORNE, Muriel Shona Director 2010-02-05 2010-09-15

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Ichor Management Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2023-11-20 Active

Filing timeline

Last 20 of 183 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-02-11 RESOLUTIONS Resolution
Date Type Category Description
2026-04-20 CS01 confirmation-statement Confirmation statement with updates PDF
2026-04-20 TM01 officers Termination director company with name termination date PDF
2026-03-06 CH01 officers Change person director company with change date PDF
2026-02-26 TM01 officers Termination director company with name termination date PDF
2025-11-03 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-10-22 AP04 officers Appoint corporate secretary company with name date PDF
2025-10-22 AP01 officers Appoint person director company with name date PDF
2025-10-22 TM01 officers Termination director company with name termination date PDF
2025-10-16 PSC05 persons-with-significant-control Change to a person with significant control PDF
2025-08-20 SH01 capital Capital allotment shares PDF
2025-08-08 SH01 capital Capital allotment shares PDF
2025-07-31 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-06-19 AA accounts Accounts with accounts type group
2025-05-29 SH01 capital Capital allotment shares PDF
2025-02-18 CS01 confirmation-statement Confirmation statement with updates PDF
2025-02-12 RP04SH01 capital Second filing capital allotment shares PDF
2025-02-11 RESOLUTIONS resolution Resolution
2025-02-10 SH01 capital Capital allotment shares PDF
2025-01-06 SH01 capital Capital allotment shares
2024-10-05 AA accounts Accounts with accounts type group

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
14

last 12 months

Capital events
6

last 24 months

Officers appointed
2

last 12 months

Officers resigned
3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page